Sign inGet started

Pamukcu Rifat

Insider CIK 1929298 · APRE Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
APRE Aprea Therapeutics, Inc. A Award deriv2026-06-162026-06-1712,555— $012,555SEC↗
APRE Aprea Therapeutics, Inc. A Award2026-06-162026-06-173,135— $08,581SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2025-06-052025-06-094,185— $04,185SEC↗
APRE Aprea Therapeutics, Inc. A Award2025-06-052025-06-091,045— $05,446SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2024-06-202024-06-214,185— $04,185SEC↗
APRE Aprea Therapeutics, Inc. A Award2024-06-202024-06-211,045— $04,401SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2023-08-232023-08-242,000— $02,000SEC↗
APRE Aprea Therapeutics, Inc. A Award2023-08-232023-08-24500— $03,356SEC↗
APRE Aprea Therapeutics, Inc. C Conversion deriv2022-08-232023-08-2427,187— $00SEC↗
APRE Aprea Therapeutics, Inc. C Conversion deriv2022-08-232023-08-244,928— $00SEC↗
APRE Aprea Therapeutics, Inc. C Conversion2022-08-232023-08-24271,870— $014,108SEC↗
APRE Aprea Therapeutics, Inc. C Conversion2022-08-232023-08-2449,280— $057,142SEC↗
APRE Aprea Therapeutics, Inc. A Award deriv2022-07-282022-08-0129,575— $029,575SEC↗
APRE Aprea Therapeutics, Inc. A Award2022-07-282022-08-015,995— $07,862SEC↗